Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Hepatology. 2019 Mar 10;69(5):2048–2060. doi: 10.1002/hep.30482

Table 3.

Treatment-Related Laboratory Adverse Events

AEs Among Patients, N=20 Grade 2, No. Grade 3, No. Grade 4, No.
Lymphocyte count decreased 13 3 2
AST increased 5 2 0
ALP increased 5 2 0
Hyponatremia 0 2 0
Platelet count decreased 2 1 0
White blood cell decreased 4 0 0
ALT increased 3 1 0
Hypophosphatemia 7 3 0
Anemia 0 6 0
Neutrophil count decreased 2 1 1
Total bilirubin increased 0 2 0